| P2093 | author name string | Chang Sik Yu | |
| | Tae Won Kim | |
| | Yoon-Koo Kang | |
| | Jin Cheon Kim | |
| | Hee Cheol Kim | |
| | Seung Do Ahn | |
| | Eun Kyung Choi | |
| | Jong Hoon Kim | |
| | Sang-wook Lee | |
| | Heung Moon Chang | |
| | Min Hee Ryu | |
| | Seong Soo Shin | |
| | Jin-hong Park | |
| P2860 | cites work | Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue | Q27863454 |
| | Capecitabine as first-line treatment in colorectal cancer. Pooled data from two large, phase III trials | Q30673291 |
| | Effective surgical adjuvant therapy for high-risk rectal carcinoma | Q33387384 |
| | Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study | Q34514696 |
| | Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study | Q34519158 |
| | Patient preferences for oral versus intravenous palliative chemotherapy | Q40915962 |
| | Radiotherapy in addition to radical surgery in rectal cancer: evidence for a dose-response effect favoring preoperative treatment | Q41382927 |
| | Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). | Q43615794 |
| | Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114. | Q43937152 |
| | Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report | Q43937156 |
| | Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer | Q44146804 |
| | Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer | Q44155882 |
| | Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer | Q59647361 |
| | Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery | Q72084377 |
| | X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts | Q73121466 |
| | Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer | Q73153260 |
| | Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients | Q73648001 |
| | Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer | Q73850876 |
| | Preoperative radiotherapy for resectable rectal cancer: A meta-analysis | Q74177972 |
| | The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, capecitabine | Q74283605 |
| | Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil | Q77332694 |
| | Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience | Q78044952 |
| | The clinicopathological significance of inferior mesenteric lymph node metastasis in colorectal cancer | Q79792437 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P921 | main subject | capecitabine | Q420207 |
| | chemoradiotherapy | Q5090613 |
| P304 | page(s) | 354-359 | |
| P577 | publication date | 2004-12-31 | |
| P1433 | published in | Cancer Research and Treatment | Q18411021 |
| P1476 | title | Prospective phase II study of preoperative chemoradiation with capecitabine in locally advanced rectal cancer | |
| P478 | volume | 36 | |